A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial) (Q73805582)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 July 2003

Language	Label	Description	Also known as
English	A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial)	scientific article published on 01 July 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

based on heuristic

inferred from title

phase III clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

object named as

David D Hurd

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Francis J Giles

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

Carole B Miller

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

John R Wingard

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

Thomas R Fleming

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

Stephen T Sonis

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

Williamson Z Bradford

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

Janis G Pulliam

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

Elias J Anaissie

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

Roy A Beveridge

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

Mark M Brunvand

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

Paul J Martin

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

PROMPT-CT Trial Investigators

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

44

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

1165-1172

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Stomatotoxic manifestations of cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Quantitative analysis of the oral complications of antileukemia chemotherapy.

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Septicemia and Shock Syndrome Due to Viridans Streptococci: A Case-Control Study of Predisposing Factors

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Failure of clindamycin to influence the course of severe oromucositis associated with streptococcal bacteraemia in allogeneic bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Effects of chlorhexidine during immunosuppressive chemotherapy. A preliminary report

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Synthesis and solution structure of the antimicrobial peptide protegrin-1.

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Iseganan HCl: a novel antimicrobial agent

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Protegrins: new antibiotics of mammalian origin

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Effect of granulocytopenia on oral microbial relationships in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Cytokines other than growth factors in bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Chlorhexidine inactivation by saliva

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Mucositis prevention by selective elimination of oral flora in irradiated head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Effect of local application of the antimicrobial peptide IB-367 on the incidence and severity of oral mucositis in hamsters

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins

1 reference

https://api.crossref.org/works/10.1080/1042819031000079159

21 January 2018

Identifiers

10.1080/1042819031000079159

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12916869 AND SRC:MED&resulttype=core&format=json

6 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73805582&oldid=2220142357"